SOPH Company Profile and Key Details
SOPHiA GENETICS SA
SOPH Stock Price Chart
Stock Price Today
SOPHiA GENETICS SA (SOPH) stock surged +12.54%, trading at $3.68 on NASDAQ, up from the previous close of $3.27. The stock opened at $3.24, fluctuating between $3.20 and $3.72 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Company Information
| Employees | 430 |
| Beta | 1.03 |
| Sales or Revenue | $62.37M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Frequently Asked Questions
SOPHiA GENETICS SA (NASDAQ: SOPH) stock price is $3.68 in the last trading session. During the trading session, SOPH stock reached the peak price of $3.72 while $3.20 was the lowest point it dropped to. The percentage change in SOPH stock occurred in the recent session was 12.54% while the dollar amount for the price change in SOPH stock was $0.41.
The NASDAQ listed SOPH is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. SOPHiA GENETICS SA designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Thierry Colin
Senior Vice President of Radiomics Bus. Area
Mr. Kevin Puylaert
Vice President of Bus. Devel. & Marketing
Mr. Abhimanyu Verma
Senior Vice President & Chief Technology Officer
Ms. Lara Hashimoto
Senior Vice President & Chief Bus. Officer
Jennifer Pottage
Head of Investor Relations
Ms. Manuela Da Silva Valente B.A.
Senior Vice President & Chief People Officer
Mr. Ross Jordan Muken B.Sc.
Executive Vice President, Chief Financial Officer & Chief Operating Officer
Dr. Philippe Menu M.B.A., M.D., Ph.D.
Executive Vice President, Chief Medical Officer & Chief Product Officer
Dr. Zhenyu Xu Ph.D.
Executive Vice President & Chief Scientific Officer
Mr. Peter Casasanto
Senior Vice President & Chief BioPharma Officer
Katherine Bailon
Vice President of Investor Relations
Dr. Jurgi Camblong M.B.A., Ph.D.
Co-Founder, Chief Executive Officer & Director
Ms. Melissa Finocchio
Senior Vice President & Chief Regulatory Officer
Mr. Daan van Well L.L.M., M.B.A.
Executive Vice President, Chief Legal Officer & Gen. Counsel
SOPH's closing price is 36.3% higher than its 52-week low of $2.70 where as its distance from 52-week high of $7.37 is -50.07%.
Number of SOPH employees currently stands at 430.
Official Website of SOPH is: https://www.sophiagenetics.com
SOPH could be contacted at phone 412 169 41060 and can also be accessed through its website. SOPH operates from Rue du Centre 172, Saint-Sulpice, 1025, Switzerland.
SOPH stock volume for the day was 284.6K shares. The average number of SOPH shares traded daily for last 3 months was 30.08K.
The market value of SOPH currently stands at $240.58M with its latest stock price at $3.68 and 65.38M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com